ARTA
SPPI

A.R.T. Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

A.R.T. Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,538
Closed -$387K – 1752
2017
Q3 		$387K Buy
+27,538
New +$249K 0.02% 916
2017
Q2 		– Sell
-20,938
Closed -$136K – 1805
2017
Q1 		$136K Buy
+20,938
New +$117K 0.01% 1234
2016
Q3 		– Sell
-205,678
Closed -$1.35M – 1263
2016
Q2 		$1.35M Buy
205,678
+94,600
+85% +$668K 0.07% 434
2016
Q1 		$706K Sell
111,078
-44,900
-29% -$230K 0.03% 727
2015
Q4 		$940K Buy
155,978
+108,310
+227% +$619K 0.04% 590
2015
Q3 		$285K Sell
47,668
-6,560
-12% -$45.5K 0.01% 1058
2015
Q2 		$370K Buy
+54,228
New +$344K 0.01% 1108
2015
Q1 		– Sell
-95,095
Closed -$659K – 1761
2014
Q4 		$659K Buy
95,095
+59,150
+165% +$435K 0.02% 821
2014
Q3 		$292K Sell
35,945
-71,496
-67% -$559K 0.01% 948
2014
Q2 		$873K Sell
107,441
-30,900
-22% -$234K 0.05% 546
2014
Q1 		$1.08M Buy
138,341
+27,506
+25% +$233K 0.06% 467
2013
Q4 		$980K Buy
110,835
+56,744
+105% +$507K 0.05% 487
2013
Q3 		$453K Sell
54,091
-174,124
-76% -$1.41M 0.02% 817
2013
Q2 		$1.7M Buy
+228,215
New +$1.75M 0.06% 444

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

A.R.T. Advisors's SPPI Position: Q4 2017 in Review

A.R.T. Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 27,538 shares — an estimated $387K sold.

A.R.T. Advisors first reported a position in SPPI in Q2 2013 and held it in 14 quarters. The position peaked at $1.7M in Q2 2013. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

  • A.R.T. Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 27,538 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $387K.
  • A.R.T. Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
  • A.R.T. Advisors's Spectrum Pharmaceuticals Inc position peaked at $1.7M in Q2 2013.
  • 157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.